The Patent Finder

Baker Norton Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Baker Norton Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Baker Norton Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,235,725Methods and compositions for the prevention of tolerance to medications
Formerly held
Term ended
Term ended Jul 28, 2019 · USPTO record
Term endedTerm ended Jul 28, 2019USPTO record
US 6,193,957Pharmaceutical compositions for treating late phase allergic reactions and inflammatory diseases
Formerly held
Term ended
Term ended May 4, 2019 · USPTO record
Term endedTerm ended May 4, 2019USPTO record
US 6,290,930Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
Term ended
Term ended Dec 18, 2018 · USPTO record
Term endedTerm ended Dec 18, 2018USPTO record
US 6,030,113Mixing apparatus and method for mixing black liquor from cellulose production with ash from flue gases formed from combustion of black liquor
Formerly held
Term ended
Term ended Jul 10, 2018 · USPTO record
Term endedTerm ended Jul 10, 2018USPTO record
US 7,056,898Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
Formerly held
Lapsed on the fee record
Ended Jun 6, 2018 · USPTO record
Lapsed on the fee recordEnded Jun 6, 2018USPTO record
US D439,325Cover for a nasal inhaler
Formerly held
Term ended
Term ended Mar 20, 2015 · USPTO record
Term endedTerm ended Mar 20, 2015USPTO record
US 6,395,770Method and compositions for administering taxanes orally to human patients
Lapsed on the fee record
Ended May 28, 2014 · USPTO record
Lapsed on the fee recordEnded May 28, 2014USPTO record
US 7,041,640Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
Lapsed on the fee record
Ended May 9, 2014 · USPTO record
Lapsed on the fee recordEnded May 9, 2014USPTO record
US 6,964,946Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
Lapsed on the fee record
Ended Nov 15, 2013 · USPTO record
Lapsed on the fee recordEnded Nov 15, 2013USPTO record
US 6,936,583Method and compositions for administering taxanes orally to human patients
Lapsed on the fee record
Ended Aug 30, 2013 · USPTO record
Lapsed on the fee recordEnded Aug 30, 2013USPTO record
10 of 49 patents shown.
Pro members see all 49.
Pro members: see all 49 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited